Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/605433


Gen-Probe Incorporated Product Pipeline Analysis


Description: Gen-Probe Incorporated Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.

Reasons to buy

- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.


Contents: 1 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Company Snapshot 7
2.1 Key Information 7
2.2 Company Overview 7
3 Gen-Probe Incorporated Pipeline Products 8
3.1 Gen-Probe Incorporated Product Pipeline Analysis 8
3.1.1 Gen-Probe Incorporated Pipeline Products By Equipment Type 8
3.1.2 Gen-Probe Incorporated Pipeline Products By Development Stage 10
3.1.3 Gen-Probe Incorporated Pipeline Products By Therapy Area 11
3.1.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials 11
3.1.5 Gen-Probe Incorporated Pipeline Products By News Summary 12
3.2 APTIMA HPV Assay 13
3.2.1 Product Status 13
3.2.2 Product Description 13
3.2.3 Product Milestone 13
3.2.4 Clinical Trials 14
3.3 PROGENSA PCA3 Assay 14
3.3.1 Product Status 14
3.3.2 Product Description 14
3.3.3 Product Milestone 15
3.3.4 Clinical Trials 15
3.4 Panther System 16
3.4.1 Product Status 16
3.4.2 Product Description 16
3.5 Methicillin-resistant Staphylococcus aureus nucleic acid test 16
3.5.1 Product Status 16
3.5.2 Product Description 17
3.5.3 Product Milestone 17
4 Recent Developments 18
4.1 Product News 18
4.1.1 Nov 21, 2008: Promising Clinical Data On Gen-Probes APTIMA HPV Test Presented At Major European Medical Meeting 18
4.1.2 Aug 13, 2008: FDA Grants Full Approval Of PROCLEIX ULTRIO Blood Screening Assay 18
4.1.3 May 28, 2008: Gen-Probe Launches In Europe CE-Marked APTIMA HPV Assay For Detection Of Human Papillomavirus 18
4.1.4 Apr 01, 2008: Gen-Probe Begins US Clinical Study Of Molecular Test For Human Papillomavirus 19
4.1.5 Mar 19, 2008: New Study Backs Use Of Gene-Based Urine Test In Prostate Cancer 20
4.1.6 May 24, 2007: FDA Approves Gen-Probes Automated PROCLEIX TIGRIS System To Test Donated Blood With The PROCLEIX ULTRIO Assay 20
4.1.7 Apr 30, 2007: 3M, Gen-Probe Form Collaboration To Develop Rapid Molecular Tests To Combat Healthcare-Associated Infections 21
4.1.8 Mar 29, 2007: Promising Data On Molecular Research Test For Prostate Cancer Published In Peer-Reviewed Journal UROLOGY 21
4.1.9 Mar 23, 2007: Results From Multi-Center European Study Highlight New Molecular Test To Improve Prostate Cancer Diagnosis 21
4.1.10 Jan 29, 2007: Gen-Probe Reports Positive Regulatory Progress for PROCLEIX ULTRIO Blood Screening Assay on the TIGRIS System 22
4.1.11 Nov 22, 2006: New, Highly Specific Gene-Based Test For Prostate Cancer Introduced In Europe 23
4.1.12 Feb 25, 2005: Gen-Probe Signs Agreement With Roche To Purchase Products For APTIMA Human Papillomavirus Assay 23
4.2 Product Approvals 23
4.2.1 Aug 13, 2008: FDA Grants Full Approval Of PROCLEIX ULTRIO Blood Screening Assay 23
4.2.2 May 24, 2007: FDA Approves Gen-Probes Automated PROCLEIX TIGRIS System To Test Donated Blood With The PROCLEIX ULTRIO Assay 24
4.3 Clinical Trials 24
4.3.1 Nov 21, 2008: Promising Clinical Data On Gen-Probes APTIMA HPV Test Presented At Major European Medical Meeting 24
4.3.2 Apr 01, 2008: Gen-Probe Begins US Clinical Study Of Molecular Test For Human Papillomavirus 25
4.3.3 Mar 19, 2008: New Study Backs Use Of Gene-Based Urine Test In Prostate Cancer 25
4.3.4 Mar 23, 2007: Results From Multi-Center European Study Highlight New Molecular Test To Improve Prostate Cancer Diagnosis 26
5 Appendix 28
5.1 Methodology 28
5.1.1 Coverage 28
5.1.2 Secondary Research 29
5.1.3 Primary Research 29
5.1.4 Expert Panel Validation 30
5.2 Contact Us 30
5.3 About us30
5.4 Disclaimer 30

Executive Summary

1.2 List of Figures
Figure 1: Gen-Probe Incorporated Pipeline Products By Equipment Type 8
Figure 2: Gen-Probe Incorporated Pipeline Products By Equipment Type 9
Figure 3: Gen-Probe Incorporated Pipeline Products By Development Stage 10
Figure 4: Gen-Probe Incorporated Pipeline Products By News Summary 12
Figure 5: Global Markets Direct Methodology 28


Companies Mentioned The following companies are the major competitors of Gen-Probe Incorporated: Abbott Molecular Inc. Becton Dickinson and Co. bioMerieux S.A. F. Hoffmann-La Roche Ltd. Ortho-Clinical Diagnostics Inc. Siemens Medical Solutions Diagnostics


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/605433

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 09:59:59
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Gen-Probe Incorporated Product Pipeline Analysis
Web Address:
http://www.researchandmarkets.com/reports/605433
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €566.00
Electronic (PDF) - Site License €1,132.00
Electronic (PDF) - Enterprisewide €1,698.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 09:59:59

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)